Find your next M&A target

Target Asia + Worldwide M&A projects with our guidance on matching, planning, due diligence & implementation.

Project details

Israeli medical company seeks investment.

Project region Israel
Industry Healthcare
Total value of the target N/A
Expected target net rate of return after deducting all taxes and fees N/A
Validity period of pending order 365


  • Simon Laube

    Simon Laube

    Assistant Manager, International Business Advisory

Project highlights cryotherapy - real time - successful preclinical trial
Project description

The Israeli medical company has developed a surface cryotherapy equipment and system, which can be inserted into the bladder through a cystoscope (endoscope) to visualize the interior of the bladder. Surface cryotherapy is a potential paradigm shift in the treatment of superficial bladder cancer. The reaction of the tissue to the frozen spray can be seen in real-time so that the therapist can assess the destruction of the tissue in real-time and has excellent visualization in all operative stages. The project adopted a new method for treating superficial bladder cancer. It uses surface cryotherapy, which uses extreme cold to freeze and destroy abnormal tissues. Its minimally invasive solution for non-muscle invasive bladder cancer (NMIBC) provides outpatient treatment options for surgery. The company announced that their cryoablation for bladder cancer has made a successful preclinical trial. The company seeks investment for next coming steps.

Enquire for more information about our services, and how we can help solve challenges for your organization

Contact Us
The code is case-sensitive